News

Capitan Orthopedics a cultivate(MD) portfolio company

Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant

News / May 5, 2026

cultivate(MD) portfolio company Capitan Orthopedics, Inc. announced that it has been granted Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its SupraSpacer™ implant. “I am excited to announce that Capitan Orthopedics, Inc. has received Breakthrough Device Designation for its SupraSpacer™ implant technology. This is yet another milestone achievement for our team […]

Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant Read More »

Shoulder Innovations is a cultivate(MD) portfolio company launching I-135RFX humeral stem

Shoulder Innovations Initiates Full Commercial Launch of the InSet® I-135RFX Humeral Stem

News / May 1, 2026

cultivate(MD) portfolio company Shoulder Innovations, Inc., (NYSE: SI) announced full commercial launch of the InSet® I-135RFX Humeral Stem. The commencement of full launch follows a successful limited market release and receipt of additional FDA 510(k) clearance for an expanded set of fracture indications, enabling the InSet™ I-135RFX to now be utilized in all primary, revision,

Shoulder Innovations Initiates Full Commercial Launch of the InSet® I-135RFX Humeral Stem Read More »

Strados Labs Acquires Clinical Trial Business of NuvoAir

News / April 16, 2026

cultivate(MD) portfolio company Strados Labs, the respiratory endpoint intelligence company, announced the acquisition of NuvoAir Clinical Trials from NuvoAir Inc. The transaction, which closed in March 2026, expands Strados’ suite of solutions to include remote and in-clinic spirometry, FeNO measurement, and electronic clinical outcome assessment (eCOA) — complementing its existing technologies for cough monitoring and

Strados Labs Acquires Clinical Trial Business of NuvoAir Read More »

Nanochon closes $4.1M Seed Prime II Funding Round

News / January 12, 2026

Nanochon, a cultivate(MD) portfolio company developing an implant for treating articular cartilage defects in the knee, has secured commitments to close an oversubscribed funding round, bringing its total capital raised to date to $11.3 million. The round was led by cultivate (MD), with significant contributions from The University of Virginia UVA Seed Fund, WSGR, Wealthing

Nanochon closes $4.1M Seed Prime II Funding Round Read More »

Prana Surgical Completes First Clinical Procedures Using the Prana System™ in Early Feasibility Study

News / January 7, 2026

First-in-human procedures mark a critical milestone supporting the system’s clinical development Prana Surgical, a cultivate(MD) portfolio company, announced the completion of the first five clinical procedures using the Prana System™ as part of its early feasibility study in Australia. The Prana System™ has been developed to enable image-guided, minimally invasive surgery, conserving healthy tissue and

Prana Surgical Completes First Clinical Procedures Using the Prana System™ in Early Feasibility Study Read More »

Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty

News / December 3, 2025

Partnership will Expand Shoulder Innovations’ Disruptive Ecosystem with Advanced Enabling Technology, Complementing Surgeon and Patient Needs in the ASC Shoulder Innovations (NYSE: SI), a cultivate(MD) portfolio company, today announced a strategic partnership with Interventional Systems (INS), a developer of robotic solutions for minimally invasive surgery, to introduce a transformative shoulder-specific micro-robotic solution designed to further

Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty Read More »